Medicare Enrolled
Dr. Colin Curran, MD
Hematology & Oncology · Hickory, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Curran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Curran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Curran
Dr. Colin Curran is a hematology & oncology specialist in Hickory, NC, with 21 years of NPI registration. Based on federal Medicare data, Dr. Curran performed 32,101 Medicare services across 2,196 unique beneficiaries.
Between the years covered by Open Payments, Dr. Curran received a total of $25,498 from 108 pharmaceutical and/or device companies across 1074 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Curran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 6% volume in NC
$25,498 industry payments
Medicare Practice Summary
Medicare Utilization ↗32,101
Medicare services
Top 6% in NC for hematology & oncology
2,196
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,529 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 9,400 | $43 | $92 |
| Denosumab injection (Prolia/Xgeva) | 7,860 | $18 | $39 |
| Iron infusion (Monoferric) | 5,300 | $17 | $36 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,730 | $5 | $15 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,490 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,379 | $8 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
809 | $94 | $167 |
| Anti-nausea injection (Aloxi/palonosetron) | 630 | $1 | $43 |
| Anti-nausea injection (ondansetron/Zofran) | 520 | $0 | $22 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
331 | $10 | $38 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
277 | $98 | $336 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
218 | $13 | $33 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
172 | $12 | $59 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
162 | $22 | $86 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
148 | $16 | $40 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
140 | $7 | $14 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
108 | $16 | $39 |
| Adrenocorticotropic hormone (ACTH) level test A blood test that measures the amount of adrenocorticotropic hormone in your body. |
106 | $38 | $91 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
99 | $134 | $243 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
98 | $49 | $185 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
95 | $0 | $0 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
94 | $47 | $184 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
75 | $54 | $114 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $62 | $115 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $119 | $271 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
62 | $21 | $75 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 61 | $344 | $853 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
58 | $8 | $10 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
58 | $23 | $122 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
56 | $2 | $15 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
54 | $0 | $14 |
| PSA test (prostate cancer screening) | 52 | $17 | $44 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
45 | $1 | $9 |
| New patient office visit, complex (60-74 min) | 43 | $169 | $345 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
41 | $28 | $70 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
33 | $18 | $45 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
33 | $9 | $39 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 28 | $20 | $50 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
28 | $69 | $145 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
22 | $18 | $146 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
17 | $3 | $14 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
13 | $10 | $34 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $135 | $315 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.8% high complexity
70.0% medium
11.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,498
Total received (2018-2024)
Avg $3,643/year across 7 years
Top 16% in NC for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
108
Companies
1,074
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,953 (74.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,683 (22.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$862 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,906
2023
$7,085
2022
$3,202
2021
$4,834
2020
$539
2019
$3,930
2018
$3,001
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$232
Novartis Pharmaceuticals Corporation
$216
Takeda Pharmaceuticals U.S.A., Inc.
$176
E.R. Squibb & Sons, L.L.C.
$170
PFIZER INC.
$165
Janssen Biotech, Inc.
$155
AstraZeneca Pharmaceuticals LP
$152
Alexion Pharmaceuticals, Inc.
$121
Eisai Inc.
$109
Daiichi Sankyo Inc.
$96
GENZYME CORPORATION
$87
Genentech USA, Inc.
$75
Exelixis Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$71
Lilly USA, LLC
$70
ACCORD HEALTHCARE, INC.
$63
PUMA BIOTECHNOLOGY, INC.
$57
BeiGene USA, Inc.
$50
SOBI, INC
$49
Incyte Corporation
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
GlaxoSmithKline, LLC.
$44
Astellas Pharma US Inc
$44
Celgene Corporation
$43
Karyopharm Therapeutics Inc.
$39
Ipsen Biopharmaceuticals, Inc
$36
JAZZ PHARMACEUTICALS INC.
$35
SpringWorks Therapeutics, Inc.
$34
Genmab U.S., Inc.
$34
Avyxa Pharma, LLC
$34
ARRAY BIOPHARMA INC
$31
SERVIER PHARMACEUTICALS LLC
$31
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Fresenius Kabi USA, LLC
$26
Gilead Sciences, Inc.
$22
Adaptive Biotechnologies Corporation
$20
Mirati Therapeutics, Inc.
$19
ABBVIE INC.
$19
Acrotech Biopharma Inc.
$18
Azurity Pharmaceuticals, Inc.
$18
Kite Pharma, Inc.
$17
Myriad Genetic Laboratories, Inc.
$17
Stemline Therapeutics Inc.
$15
Top 3 companies account for 21.5% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$4,518
AstraZeneca Pharmaceuticals LP
$2,511
E.R. Squibb & Sons, L.L.C.
$1,390
Novartis Pharmaceuticals Corporation
$1,340
Genentech USA, Inc.
$1,339
Janssen Biotech, Inc.
$1,098
Amgen Inc.
$1,086
PFIZER INC.
$883
Takeda Pharmaceuticals U.S.A., Inc.
$661
Daiichi Sankyo Inc.
$644
GENZYME CORPORATION
$588
Astellas Pharma US Inc
$588
Merck Sharp & Dohme LLC
$522
Merck Sharp & Dohme Corporation
$484
Lilly USA, LLC
$426
Celgene Corporation
$398
GlaxoSmithKline, LLC.
$378
Eisai Inc.
$373
Exelixis Inc.
$304
Alexion Pharmaceuticals, Inc.
$296
Seagen Inc.
$222
Ipsen Biopharmaceuticals, Inc
$218
Gilead Sciences, Inc.
$205
Regeneron Healthcare Solutions, Inc.
$183
UCB, Inc.
$182
EISAI INC.
$170
AbbVie Inc.
$165
Karyopharm Therapeutics Inc.
$152
AVEO Pharmaceuticals, Inc.
$143
BeiGene USA, Inc.
$141
Janssen Scientific Affairs, LLC
$130
Bayer HealthCare Pharmaceuticals Inc.
$123
PUMA BIOTECHNOLOGY, INC.
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$120
ARRAY BIOPHARMA INC
$118
Bayer Healthcare Pharmaceuticals Inc.
$116
JAZZ PHARMACEUTICALS INC.
$116
EMD Serono, Inc.
$98
Epizyme, Inc.,
$89
AMAG Pharmaceuticals, Inc.
$87
Grifols USA, LLC
$84
G1 Therapeutics, Inc.
$81
Octapharma USA, Inc.
$81
Sobi, Inc
$79
Horizon Therapeutics plc
$76
ABBVIE INC.
$75
Taiho Oncology, Inc.
$74
Foundation Medicine, Inc.
$69
Pharmacyclics LLC, An AbbVie Company
$69
Stemline Therapeutics Inc.
$67
Acrotech Biopharma LLC
$65
Kite Pharma, Inc.
$65
Novocure Inc.
$64
ACCORD HEALTHCARE, INC.
$63
Genmab U.S., Inc.
$63
Sun Pharmaceutical Industries Inc.
$63
AbbVie, Inc.
$58
Acrotech Biopharma Inc.
$56
Teva Pharmaceuticals USA, Inc.
$56
TOLMAR Pharmaceuticals, Inc.
$52
Deciphera Pharmaceuticals Inc.
$49
Mirati Therapeutics, Inc.
$49
Shire North American Group Inc
$49
SOBI, INC
$49
Pharmacyclics LLC, an AbbVie Company
$48
Dova Pharmaceuticals
$46
ADC Therapeutics America, Inc.
$46
Myriad Genetic Laboratories, Inc.
$45
Inari Medical, Inc.
$45
SERVIER PHARMACEUTICALS LLC
$45
Coherus Biosciences Inc.
$40
Cardinal Health 108, LLC
$40
Fresenius Kabi USA, LLC
$39
Secura Bio, Inc.
$39
Seattle Genetics, Inc.
$38
MEDIVATION FIELD SOLUTIONS LLC
$38
Organon LLC
$37
Puma Biotechnology, Inc.
$36
EUSA Pharma (US) LLC
$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$35
SpringWorks Therapeutics, Inc.
$34
Servier Pharmaceuticals LLC
$34
Avyxa Pharma, LLC
$34
TG Therapeutics, Inc.
$32
Clovis Oncology, Inc.
$29
Acceleron Pharma, Inc.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Lexicon Pharmaceuticals, Inc.
$25
Agios Pharmaceuticals, Inc.
$22
Mylan Institutional Inc.
$20
Adaptive Biotechnologies Corporation
$20
Sysmex Inostics Inc
$19
Sirtex Medical Inc
$19
GE HealthCare
$18
Roche Diagnostics Corporation
$18
Amneal Pharmaceuticals LLC
$18
Azurity Pharmaceuticals, Inc.
$18
Kyowa Kirin, Inc.
$18
PharmaEssentia USA Corporation
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$15
RECORDATI_RARE_DISEASES_INC.
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Medtronic USA, Inc.
$13
Nestle HealthCare Nutrition Inc.
$12
Heron Therapeutics, Inc.
$12
Aveo Pharmaceuticals, Inc.
$12
Verastem, Inc.
$11
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$7
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · Actemra · Alecensa · Alphanate · Aranesp · BAVENCIO · BELEODAQ · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · CAMZYOS · CARVYKTI · CERDELGA · CEREZYME · COSELA · CREON · CYRAMZA · Cabometyx · Cimzia · Copiktra · DARZALEX · DOPTELET · Docivyx · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · Enbrel · Enhertu · Epkinly · Erleada · FARESTON · FARYDAK · FEMARA · FERAHEME · FLOWTRIEVER CATHETER · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Fulphila · GATTEX · GAZYVA · GILOTRIF · Gamunex-C · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · KYPHON Balloon Kyphoplasty · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · LifeVest · Lonsurf · Lupron · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NAVIFY Products · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO (sonidegib) capsules · OGSIVEO · ONTRUZANT · OPDIVO · OPDUALAG · ORENCIA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RELISTOR · RENFLEXIS · RYBREVANT · Reblozyl · Revlimid · Rubraca · S · SANDOSTATIN · SARCLISA · SCEMBLIX · SIMPONI · SIMPONI ARIA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · STELARA · SUSTOL · SUTENT · SYLVANT · SYNAGIS · Somatuline Depot · Stimufend · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALTZ · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TREMFYA · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tecentriq · Thrombate III · Tibsovo · Tivdak · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Vectibix · Venclexta · Vitrakvi · WELIREG · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
7
Per 100K population
4.3
County median income
$64,544
Nearest hospital
CATAWBA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Curran is a mixed practice specialist, with above-average Medicare volume (top 6% in NC), with low-engagement industry engagement in the top 16% of NC peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Curran experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Curran performed 9,400 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Curran receive payments from pharmaceutical companies?
Yes. Dr. Curran received a total of $25,498 from 108 companies across 1,074 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Curran's costs compare to other hematology & oncology specialists in Hickory?
Dr. Curran's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Curran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Hickory
Browse hematology & oncology specialists in Hickory ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NC
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NC
Which NC hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology